Burkitt's lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
Kamal Akbar (talk | contribs) No edit summary |
Kamal Akbar (talk | contribs) No edit summary |
||
| Line 7: | Line 7: | ||
Common risk factors in the development of Burkitt's lymphoma may include:<ref name="pmid29676453">{{cite journal| author=Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN et al.| title=Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. | journal=Br J Haematol | year= 2018 | volume= 181 | issue= 4 | pages= 505-514 | pmid=29676453 | doi=10.1111/bjh.15229 | pmc=5980720 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29676453 }} </ref> | Common risk factors in the development of Burkitt's lymphoma may include:<ref name="pmid29676453">{{cite journal| author=Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN et al.| title=Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. | journal=Br J Haematol | year= 2018 | volume= 181 | issue= 4 | pages= 505-514 | pmid=29676453 | doi=10.1111/bjh.15229 | pmc=5980720 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29676453 }} </ref> | ||
* [[HIV]]/[[AIDS]]<ref name="pmid29663523">{{cite journal| author=Meister A, Hentrich M, Wyen C, Hübel K| title=Malignant lymphoma in the HIV-positive patient. | journal=Eur J Haematol | year= 2018 | volume= 101 | issue= 1 | pages= 119-126 | pmid=29663523 | doi=10.1111/ejh.13082 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29663523 }} </ref> | * [[HIV]]/[[AIDS]]<ref name="pmid29663523">{{cite journal| author=Meister A, Hentrich M, Wyen C, Hübel K| title=Malignant lymphoma in the HIV-positive patient. | journal=Eur J Haematol | year= 2018 | volume= 101 | issue= 1 | pages= 119-126 | pmid=29663523 | doi=10.1111/ejh.13082 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29663523 }} </ref> | ||
* Post-transplant immunosuppression | * Post-transplant immunosuppression<ref name="pmid23466659">{{cite journal| author=Naik S, Tayapongsak K, Robbins K, Manavi CK, Pettenati MJ, Grier DD| title=Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature. | journal=Case Rep Oncol | year= 2013 | volume= 6 | issue= 1 | pages= 6-14 | pmid=23466659 | doi=10.1159/000346346 | pmc=3573821 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23466659 }} </ref> | ||
*Solid organ transplant<ref name="pmid23386365">{{cite journal| author=Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD et al.| title=Burkitt lymphoma risk in U.S. solid organ transplant recipients. | journal=Am J Hematol | year= 2013 | volume= 88 | issue= 4 | pages= 245-50 | pmid=23386365 | doi=10.1002/ajh.23385 | pmc=3608801 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23386365 }} </ref> | |||
* [[Malaria]]<ref name="pmid29676453">{{cite journal| author=Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN et al.| title=Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. | journal=Br J Haematol | year= 2018 | volume= 181 | issue= 4 | pages= 505-514 | pmid=29676453 | doi=10.1111/bjh.15229 | pmc=5980720 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29676453 }} </ref> | * [[Malaria]]<ref name="pmid29676453">{{cite journal| author=Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN et al.| title=Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. | journal=Br J Haematol | year= 2018 | volume= 181 | issue= 4 | pages= 505-514 | pmid=29676453 | doi=10.1111/bjh.15229 | pmc=5980720 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29676453 }} </ref> | ||
Revision as of 16:57, 9 January 2019
|
Burkitt's lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Burkitt's lymphoma risk factors On the Web |
|
American Roentgen Ray Society Images of Burkitt's lymphoma risk factors |
|
Risk calculators and risk factors for Burkitt's lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Common risk factors in the development of Burkitt's lymphoma may be HIV/AIDS and post-transplant immunosuppression. There are no risk factors for childhood Burkitt's lymphoma.
Risk Factors
Common risk factors in the development of Burkitt's lymphoma may include:[1]
References
- ↑ 1.0 1.1 Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN; et al. (2018). "Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink". Br J Haematol. 181 (4): 505–514. doi:10.1111/bjh.15229. PMC 5980720. PMID 29676453.
- ↑ Meister A, Hentrich M, Wyen C, Hübel K (2018). "Malignant lymphoma in the HIV-positive patient". Eur J Haematol. 101 (1): 119–126. doi:10.1111/ejh.13082. PMID 29663523.
- ↑ Naik S, Tayapongsak K, Robbins K, Manavi CK, Pettenati MJ, Grier DD (2013). "Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature". Case Rep Oncol. 6 (1): 6–14. doi:10.1159/000346346. PMC 3573821. PMID 23466659.
- ↑ Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD; et al. (2013). "Burkitt lymphoma risk in U.S. solid organ transplant recipients". Am J Hematol. 88 (4): 245–50. doi:10.1002/ajh.23385. PMC 3608801. PMID 23386365.